Literature DB >> 6972335

Human colonic mononuclear cells: studies of cytotoxic function.

Z M Falchuk, E Barnhard, I Machado.   

Abstract

We isolated lymphocytes from the lamina propria of colon from 19 patients with inflammatory bowel disease, colon cancer, and certain benign conditions to determine: (1) if these lymphocytes could mediate mitogen-induced (MICC) and spontaneous cell-mediated cytotoxicity (SCMC), and (2) if there were any differences in cytotoxic effectiveness which could relate to the underlying disease. We found that lamina propria lymphocytes functioned well in MICC reactions with phytohaemagglutinin, but not concanavalin A as the inducing mitogen (specific lysis 28 5% vs 5 3%). Lamina propria lymphocytes did not mediate SCMC (specific lysis 0.3%). Neither the presence of inflammation not the underlying disease of the patient influenced the cytotoxic activity. Peripheral blood lymphocytes from normal subjects and patients performed well in MICC assay with both phytohaemagglutinin and concanvalin A as the inducing mitogen and were equally effective in SCMC reactions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972335      PMCID: PMC1419163          DOI: 10.1136/gut.22.4.290

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  PHYTOHAEMAGGLUTININ-INDUCED CYTOTOXIC ACTION OF NORMAL LYMPHOID CELLS ON CELLS IN TISSUE CULTURE.

Authors:  G HOLM; P PERLMANN; B WERNER
Journal:  Nature       Date:  1964-08-22       Impact factor: 49.962

2.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

3.  Morphologic and functional characteristics of human intestinal lymphoid cells isolated by a mechanical technique.

Authors:  R Goodacre; R Davidson; D Singal; J Bienenstock
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

4.  Characteristics of isolated intestinal mucosal lymphoid cells in inflammatory bowel disease.

Authors:  M A Bookman; D M Bull
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

Review 5.  Update on gluten-sensitive enteropathy.

Authors:  Z M Falchuk
Journal:  Am J Med       Date:  1979-12       Impact factor: 4.965

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes.

Authors:  P Perlmann; H Perlmann
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

8.  Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities.

Authors:  R P MacDermott; G O Franklin; K M Jenkins; I J Kodner; G S Nash; I J Weinrieb
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

9.  K-Cell activity in lamina proprial lymphocytes from the human colon.

Authors:  M Chiba; R G Shorter; W R Thayer; W Bartnik; S ReMine
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

10.  Cytotoxic activities of gut mucosal lymphoid cells in guinea pigs.

Authors:  F Arnaud-Battandier; B M Bundy; M O'Neill; J Bienenstock; D L Nelson
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

View more
  12 in total

1.  Isolation of intestinal mononuclear cells: factors released which affect lymphocyte viability and function.

Authors:  P R Gibson; A Hermanowicz; H J Verhaar; D J Ferguson; A L Bernal; D P Jewell
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

2.  Immunoelectron microscopic localization of HLA-DR antigen in control small intestine and colon and in inflammatory bowel disease.

Authors:  I Hirata; L L Austin; W H Blackwell; J R Weber; W O Dobbins
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

3.  Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.

Authors:  W S Selby; G Janossy; M Bofill; D P Jewell
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

4.  Natural killer cells and spontaneous cell-mediated cytotoxicity in the human intestine.

Authors:  P R Gibson; E L Dow; W S Selby; R G Strickland; D P Jewell
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

5.  Definite spontaneous cell-mediated cytotoxicity and HNK-1 cells in the human large intestine.

Authors:  M Chiba; H Ohta; O Masamune; Y Yoshida
Journal:  Gastroenterol Jpn       Date:  1986-12

6.  Factors affecting the spontaneous cell-mediated cytotoxicity of intestinal mononuclear cells.

Authors:  P R Gibson; A Hermanowicz; D P Jewell
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

7.  Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro.

Authors:  J K Roche; C Fiocchi; K Youngman
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease.

Authors:  C Fiocchi; K R Youngman; R G Farmer
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

9.  Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease.

Authors:  A Zifroni; A J Treves; D B Sachar; D Rachmilewitz
Journal:  Gut       Date:  1983-07       Impact factor: 23.059

10.  Anti-CD2 and anti-CD3 induced T cell cytotoxicity of human intraepithelial and lamina propria lymphocytes.

Authors:  J Rüthlein; G Heinze; I O Auer
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.